查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776193

S狀結腸鏡子的全球市場:洞察，競爭情形，市場預測:2032年

Sigmoidoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計在2025年至2032年的預測期內，乙狀結腸鏡市場將以5.57%的複合年增長率擴張。由於大腸直腸癌、發炎性腸道疾病 (IBD)、憩室炎和息肉等慢性疾病的增多、老齡人口的增長、人們對胃腸道疾病早期診斷意識的增強以及向微創手術的日益轉變，乙狀結腸鏡市場正在經歷顯著增長，所有這些因素預計都將在2025年至2032年的預測期內對乙狀鏡的需求增長。

乙狀結腸鏡市場動態：

根據全球癌症觀察組織 (Global Cancer Observatory) 2024 年的數據，大腸直腸癌在亞洲佔50.2%，在歐洲佔27.9%，非洲為3.7%。根據同一數據來源顯示，2022年全球將新增約139萬例大腸癌病例，預計2045年將達到329萬例。隨著早期發現和診斷需求的不斷增長，日益加重的全球負擔顯著推動了對乙狀結腸鏡的需求。

乙狀結腸鏡在結直腸癌的早期發現中發揮關鍵作用。它們使醫生能夠直接觀察直腸和乙狀結腸，而癌症和息肉在這些部位最為常見。因此，乙狀結腸鏡正成為預防性醫療保健和常規診斷方案的重要組成部分。

此外，世界胃腸病學組織（2024年）報告稱，49%的女性和36.6%的男性符合至少一種功能性胃腸病（FGID）的診斷標準。最常見的疾病是功能性便秘（11.7%）、功能性消化不良（7.2%）、直腸疼痛（5.9%）、功能性腹瀉（4.7%）和腸躁症 (IBS)（4.1%）。由於許多此類疾病需要直接檢查直腸和乙狀結腸才能進行準確診斷和製定治療計劃，因此醫院、診所和胃腸病中心對乙狀結腸鏡檢查的採用正在迅速增加。

此外，隨著全球癌症發生率預計會增加，醫療保健系統正在增加對先進診斷工具和技術的投資。早期發現和預防保健變得越來越重要。例如，2024 年 1 月，奧林巴斯株式會社以 3.7 億美元收購了泰熊醫療株式會社。此次策略性收購旨在擴大奧林巴斯的胃腸治療產品組合，並增強其在胃腸疾病診斷和治療設備方面的能力。

此外，根據世界衛生組織 (WHO) (2024) 的預測，到 2050 年，全球約 80% 的老年人口將居住在中低收入國家。由於老年人更容易患上需要早期診斷的胃腸道疾病，預計對乙狀結腸鏡等便捷診斷解決方案的需求將大幅增長，尤其是在新興市場。

因此，預計在 2025 年至 2032 年的預測期內，結直腸癌發病率上升、功能性胃腸道疾病 (FGID) 患病率上升、老年人口增長以及醫療保健進步等因素將推動乙狀結腸鏡市場強勁增長。

然而，由於替代診斷方法的可用性、乙狀結腸鏡檢查相關的併發症和感染的潛在風險以及患者不適，乙狀結腸鏡可能面臨某些限制，這可能會阻礙其廣泛應用。

乙狀結腸鏡市場區隔分析：

乙狀結腸鏡市場分析，按產品類型（硬性、柔性）、用途（一次性、可重複使用）、最終用戶（醫院和診所、門診手術中心、其他）和地區（北美、歐洲、亞太地區、其他）進行

按產品類型劃分，柔性乙狀結腸鏡預計將在2024年佔據相當大的收入佔有率。這是因為它們相比硬性型號具有許多優勢。柔性乙狀結腸鏡的日益普及，極大地推動了整個乙狀結腸鏡市場的發展，這主要得益於其臨床實用性、患者舒適度的提升以及技術的不斷發展。與硬性乙狀結腸鏡不同，柔性乙狀結腸鏡可以更深入地觀察乙狀結腸，並提高操作靈活性，使醫生能夠更準確地發現異常。

此外，這些儀器更容易取得且經濟高效，因為它們疼痛程度較低，通常無需鎮靜，並且可以在門診進行。例如，全球內視鏡領域的領導者奧林巴斯公司在其 EVIS EXERA III 平台中提供先進的柔性乙狀結腸鏡，該平台以其高清影像和窄帶成像 (NBI) 技術而聞名，可增強黏膜的可視化，從而提高結腸息肉和早期癌性病變的檢出率。賓得醫療生產的柔性視訊乙狀結腸鏡（例如 EC-3490LK）採用人體工學設計和 HD+ 視覺化技術，廣泛應用於胃腸病房和診所。這些技術創新使得柔性乙狀結腸鏡檢查在常規大腸篩檢中更具吸引力，尤其是在醫療保健系統日益重視大腸癌預防保健的當下。

此外，像 Ambu A/S 這樣的公司已經推出了一次性柔性乙狀結腸鏡，例如 Ambu® aScope Gastro，它在提供便利性和無菌性的同時，也解決了感染控制問題。柔性乙狀結腸鏡被納入國家癌症篩檢項目，例如英國國家醫療服務體系 (NHS) 的腸鏡篩檢項目，這進一步加速了其臨床應用。總體而言，對柔性乙狀結腸鏡日益增長的依賴，加上光學清晰度、數位成像和一次性使用形式的改進，正在推動全球乙狀結腸鏡市場的成長。

預計北美將主導整個乙狀結腸鏡市場：

在所有地區中，預計北美將在2024年主導乙狀結腸鏡市場。這可以歸因於多種因素，包括技術進步、監管部門的批准、主要參與者的龐大市場佔有率、對醫療基礎設施的持續投資，以及創新產品開髮帶來的結直腸癌患者數量的增加，預計這些因素將在2025年至2032年的預測期內推動乙狀結腸鏡市場的發展。

根據國際癌症研究機構（2024年）的數據，北美將新增約18.4萬例大腸直腸癌病例，預計到2050年這一數字將增至25萬例。隨著大腸直腸癌發生率的持續上升，早期發現和有效篩檢方法的需求變得越來越重要。乙狀結腸鏡檢查是檢查直腸和乙狀結腸的重要診斷程序，在檢測和監測大腸直腸異常方面發揮著至關重要的作用。隨著大腸直腸癌負擔的增加，對乙狀結腸鏡檢查的需求也日益增長，醫療保健提供者也越來越依賴這項工具進行及時診斷和介入。

此外，美國胃腸病學會 (AGA) 報告指出（2024 年），約有 6,000 萬至 7,000 萬美國人患有胃腸道 (GI) 疾病。發炎性腸道疾病 (IBD)、潰瘍性結腸炎、直腸炎、憩室病和結腸息肉等疾病的盛行率不斷上升，進一步推動了對乙狀結腸鏡的需求。這些疾病通常會影響下消化道，尤其是直腸和乙狀結腸，使用乙狀結腸鏡進行觀察效果最佳。例如，潰瘍性結腸炎患者通常需要定期進行乙狀結腸鏡檢查，以監測黏膜發炎並評估治療效果。

此外，由於強生服務公司、奧林巴斯公司和百特等主要公司擁有強大的分銷網絡，乙狀結腸鏡在該地區廣泛普及。此外，優惠的報銷政策進一步推動了乙狀結腸鏡的普及，創造了巨大的市場成長機會。

總而言之，大腸直腸癌和消化系統疾病盛行率的上升，加上技術的可及性、強大的市場參與者和支持性的醫療政策，預計將推動北美乙狀結腸鏡市場的顯著增長。

乙狀結腸鏡市場的主要參與者

乙狀結腸鏡市場的主要參與者包括奧林巴斯公司、百特公司、阿德勒儀器公司、Bioseal公司、Rocket Medical plc.、康美公司、強生服務公司、美敦力公司、Ambu A/S公司、SCHOLLY FIBEROPTIC GMBH公司、SonoScape Medical Corp.、Interscope公司和Ovesco Endospycopy 公司。

乙狀結腸鏡市場的最新發展：

  • 2024年2月，富士軟片印度公司在印度推出了突破性的ALOKA ARIETTA 850診斷超音波系統。這款高科技超音波系統旨在提高該地區胃腸道疾病的診斷準確性和影像清晰度。
  • 2023年5月，奧林巴斯宣布EVIS X1內視鏡系統及兩款相容的胃腸內視鏡獲得FDA批准。 GIF-1100胃腸內視鏡適用於上消化道，包括食道、胃和十二指腸；CF-HQ1100DL/I結腸內視鏡適用於下消化道，包括肛門、直腸、乙狀結腸、結腸和迴盲瓣。

乙狀結腸鏡市場研究報告重點

  • 乙狀結腸鏡目前市場規模分析（2024 年）及八年市場預測（2025-2032 年）
  • 過去三年主要產品/服務開發、併購、合作及合資企業
  • 主導乙狀結腸鏡市場的主要公司
  • 乙狀結腸鏡市場競爭對手面臨的各種機會
  • 哪些細分市場將在 2024 年名列前茅？這些細分市場在 2032 年的表現
  • 目前乙狀結腸鏡市場情勢下的主要地區和國家
  • 未來公司應關注乙狀結腸鏡市場成長機會的地區和國家

乙狀結腸鏡市場常見問題

1.乙狀結腸鏡

  • 乙狀結腸鏡是一種用於檢查直腸和乙狀結腸（大腸下部）的醫療器材。它常用於診斷和治療，例如識別異常（息肉、發炎和癌症）、監測發炎性腸道疾病以及進行活檢。

2. 乙狀結腸鏡市場

  • 預計在 2025 年至 2032 年的預測期內，乙狀結腸鏡市場將以 5.57% 的複合年增長率成長。

3.推動乙狀結腸鏡市場發展的因素

  • 乙狀結腸鏡市場的主要參與者包括奧林巴斯公司、百特公司、阿德勒儀器公司、Bioseal公司、Rocket Medical plc.、ConMed公司、強生服務公司、美敦力公司、Ambu A/S公司、SCHOLLY FIBEROPTIC GMBH公司、SonoScape Medical Corp.、Interscope公司和Ovesco Endospycopy 公司。

5.乙狀結腸鏡市佔率最大的地區

  • 在所有地區中，預計北美將在2024年佔據乙狀結腸鏡市場的主導地位。這可以歸因於多種因素，包括技術進步、監管部門的批准、大型公司的龐大市場佔有率、對醫療基礎設施的持續投資，以及創新產品開髮帶來的結直腸癌患者數量的增加，預計這些因素將在2025年至2032年的預測期內推動乙狀結腸鏡市場的發展。

目錄

第1章 S狀結腸鏡市場報告的簡介

第2章 S狀結腸鏡子市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 S狀結腸鏡子市場主要原因分析

  • 乙狀結腸鏡市場推動因素
    • 大腸直腸癌和胃腸道疾病發生率上升
    • 老化人口成長
    • 胃腸道疾病早期診斷意識增強
  • 乙狀結腸鏡市場限制與挑戰
    • 替代方案的可用性
    • 與這些裝置相關的併發症和感染風險
  • 乙狀結腸鏡的市場機遇
    • 乙狀結腸鏡與遠距醫療平台的整合以及AI輔助診斷

第6章 乙狀結腸鏡市場波特的五力分析

第7章 S狀結腸鏡子市場評估

  • 各產品類型
    • 硬式
    • 軟性
  • 按實用性
    • 拋棄式
    • 再利用型
  • 各終端用戶
    • 醫院和診療所
    • 門診病人手術中心
    • 其他
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 S狀結腸鏡子市場企業與產品簡介

  • Olympus Corporation
  • Baxter
  • Adler Instrument Company
  • Bioseal Inc.
  • Rocket Medical plc.
  • ConMed Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Ambu A/S
  • SCHOLLY FIBEROPTIC GMBH
  • SonoScape Medical Corp.
  • Interscope, Inc.
  • Ovesco Endoscopy AG

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0203

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2032 owing to the increasing instances of chronic conditions and rising awareness about early diagnosis of gastro-intestinal disorders globally.

The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032. The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

Sigmoidoscopes Market Dynamics:

According to the Global Cancer Observatory (2024), colorectal cancer accounted for 50.2% of cancer cases in Asia, 27.9% in Europe, and 3.7% in Africa. The same source also reported that in 2022, there were approximately 1.39 million cases of colorectal cancer worldwide, a number projected to reach 3.29 million by 2045. This rising global burden is significantly driving the demand for sigmoidoscopes, as the need for early detection and diagnosis continues to grow.

Sigmoidoscopy plays a critical role in the early identification of colorectal cancer. It allows physicians to directly visualize the rectum and sigmoid colon, which are common sites for cancer and polyps. As a result, sigmoidoscopes are increasingly becoming a key component of preventive healthcare and routine diagnostic protocols.

In addition, the World Gastroenterology Organization (2024) reported that 49% of females and 36.6% of males met the criteria for at least one functional gastrointestinal disorder (FGID). The most prevalent disorders included functional constipation (11.7%), functional dyspepsia (7.2%), proctalgia fugax (5.9%), functional diarrhea (4.7%), and irritable bowel syndrome (IBS) (4.1%). Since many of these conditions require direct examination of the rectum and sigmoid colon for accurate diagnosis and treatment planning, the adoption of sigmoidoscopy procedures has surged across hospitals, clinics, and gastroenterology centers.

Furthermore, with the expected rise in global cancer incidence, healthcare systems are increasingly investing in advanced diagnostic tools and technologies. A greater emphasis is being placed on early detection and preventive care. For instance, in January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd. for USD 370 million. This strategic acquisition is aimed at expanding Olympus's gastrointestinal endotherapy portfolio and strengthening its capabilities in both diagnostic and therapeutic devices for GI disorders.

Moreover, according to the World Health Organization (2024), by 2050, around 80% of the global elderly population will reside in low- and middle-income countries. As older adults are more prone to gastrointestinal issues that require early diagnosis, the demand for accessible diagnostic solutions such as sigmoidoscopes is expected to increase significantly, especially in emerging markets.

Therefore, the combination of rising colorectal cancer prevalence, increasing incidence of FGIDs, growing geriatric population, and healthcare advancements is anticipated to drive robust growth in the sigmoidoscope market during the forecast period from 2025 to 2032.

However, the market may face certain limitations due to the availability of alternative diagnostic methods, potential risks of complications and infections associated with sigmoidoscopy, and patient discomfort, which could hinder its widespread adoption.

Sigmoidoscopes Market Segment Analysis:

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of sigmoidoscopes, the flexible category is expected to have a significant revenue share in the year 2024. This is due to the numerous advantages over rigid models. The growing adoption of flexible sigmoidoscopes is significantly boosting the overall market for sigmoidoscopes, largely due to their enhanced clinical utility, patient comfort, and evolving technology. Unlike rigid sigmoidoscopes, flexible variants allow for deeper navigation of the sigmoid colon and better maneuverability, enabling physicians to detect abnormalities with greater accuracy.

Additionally, these devices are less painful, often do not require sedation, and allow for procedures to be performed in outpatient settings, making them more accessible and cost-effective. For instance, Olympus Corporation, a global leader in endoscopy, offers advanced flexible sigmoidoscopes that are part of its EVIS EXERA III platform, known for high-definition imaging and Narrow Band Imaging (NBI) technology that enhances mucosal visualization. This allows for improved detection of colorectal polyps and early-stage cancer lesions. Another notable example is Pentax Medical, which manufactures flexible video sigmoidoscopes such as the EC-3490LK, featuring ergonomic design and HD+ visualization, widely used in GI units and clinics. These innovations have made flexible sigmoidoscopy more appealing for routine colorectal screenings, especially as health systems emphasize preventive care for colorectal cancer.

Additionally, companies like Ambu A/S have introduced single-use flexible sigmoidoscopes, such as the Ambu(R) aScope Gastro, addressing infection control concerns while offering convenience and sterility. The integration of flexible sigmoidoscopy into national cancer screening programs such as the NHS Bowel Scope Screening in the UK has further accelerated its clinical adoption. Overall, the increasing reliance on flexible sigmoidoscopes, combined with improvements in optical clarity, digital imaging, and single-use formats, is playing a pivotal role in driving the growth of the sigmoidoscope market globally.

North America is expected to dominate the overall sigmoidoscopes market:

Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

According to data from the International Agency for Research on Cancer (2024), the number of new colorectal cancer cases in North America was approximately 184,000, and this figure is projected to rise to 250,000 by 2050. As the incidence of colorectal cancer continues to increase, the need for early detection and effective screening methods becomes more critical. Sigmoidoscopy, a key diagnostic procedure for examining the rectum and sigmoid colon, plays a vital role in identifying and monitoring colorectal abnormalities. With the rising burden of colorectal cancer, the demand for sigmoidoscopes is growing, as healthcare providers increasingly rely on this tool for timely diagnosis and intervention.

Additionally, the American Gastroenterological Association (2024) reported that approximately 60-70 million Americans are affected by gastrointestinal (GI) diseases. The increasing prevalence of conditions such as inflammatory bowel disease (IBD), ulcerative colitis, proctitis, diverticulosis, and colorectal polyps is further driving the demand for sigmoidoscopes. These disorders commonly affect the lower gastrointestinal tract, specifically the rectum and sigmoid colon areas, best visualized using a sigmoidoscope. For instance, patients with ulcerative colitis often require regular sigmoidoscopic evaluations to monitor mucosal inflammation and assess treatment response.

Moreover, the presence of key industry players such as Johnson & Johnson Services, Inc., Olympus Corporation, and Baxter, backed by robust distribution networks, ensures wide accessibility and availability of sigmoidoscopes across the region. In addition, favorable reimbursement policies further support adoption, creating significant market growth opportunities.

In conclusion, the rising prevalence of colorectal cancer and GI diseases, combined with technological accessibility, strong market players, and supportive healthcare policies, are expected to foster substantial growth for the sigmoidoscope market in North America.

Sigmoidoscopes Market Key Players:

Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

Recent Developmental Activities in the Sigmoidoscopes Market:

  • In February 2024, FUJIFILM India launched the groundbreaking ALOKA ARIETTA 850 Diagnostic Ultrasound System in India, representing a significant advancement in endoscopic technologies. The high-tech ultrasound system aimed to enhance diagnostic precision and image clarity for gastrointestinal diseases in the region.
  • In May 2023, Olympus announced the FDA clearance of the EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes. The GIF-1100 gastrointestinal videoscope was indicated for use within the upper digestive tract, including the esophagus, stomach, and duodenum, while the CF-HQ1100DL/I colonovideoscope was indicated for use within the lower digestive tract, including the anus, rectum, sigmoid colon, colon, and ileocecal valve.

Key takeaways from the sigmoidoscopes market report study

  • Market size analysis for current sigmoidoscopes market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the sigmoidoscopes market
  • Various opportunities available for the other competitors in the sigmoidoscopes market space
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current sigmoidoscopes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for sigmoidoscopes market growth in the coming future?

Target audience who can benefit from this sigmoidoscope market report study

  • Sigmoidoscopes product providers
  • Research organizations and consulting companies
  • Sigmoidoscopes-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in sigmoidoscopes
  • Various end-users who want to know more about the sigmoidoscopes market and the latest developments in the sigmoidoscopes market

Frequently Asked Questions for the Sigmoidoscopes Market:

1. What are sigmoidoscopes?

  • The sigmoidoscope is a medical device used for examining the rectum and sigmoid colon, which is the lower part of the large intestine. It is commonly used in diagnostic and therapeutic procedures, such as identifying abnormalities (polyps, inflammation, or cancer), monitoring inflammatory bowel disease, and performing biopsies.

2. What is the market for sigmoidoscopes?

  • The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032.

3. What are the drivers for the sigmoidoscopes market?

  • The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

4. Who are the key players operating in the sigmoidoscopes market?

  • Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

5. Which region has the highest share in the sigmoidoscopes market?

  • Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

Table of Contents

1. Sigmoidoscopes Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Sigmoidoscopes Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Sigmoidoscopes Market Key Factors Analysis

  • 5.1. Sigmoidoscopes Market Drivers
    • 5.1.1. Increasing instances of colorectal cancer and gastrointestinal disorders
    • 5.1.2. Increasing geriatric population
    • 5.1.3. Rising awareness about the early diagnosis of gastrointestinal disorders
  • 5.2. Sigmoidoscopes Market Restraints and Challenges
    • 5.2.1. Availability of alternative options
    • 5.2.2. Risk of complications and infections associated with these devices
  • 5.3. Sigmoidoscopes Market Opportunities
    • 5.3.1. Integration of sigmoidoscopes with telemedicine platforms and AI-assisted diagnostics

6. Sigmoidoscopes Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Sigmoidoscopes Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Rigid
    • 7.1.2. Flexible
  • 7.2. By Usability
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By End-User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.3. India Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Sigmoidoscopes Market Size in USD million (2022-2032)

8. Sigmoidoscopes Market Company and Product Profiles

  • 8.1. Olympus Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Baxter
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Adler Instrument Company
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Bioseal Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rocket Medical plc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. ConMed Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Johnson & Johnson Services, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Ambu A/S
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. SCHOLLY FIBEROPTIC GMBH
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. SonoScape Medical Corp.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Interscope, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Ovesco Endoscopy AG
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Sigmoidoscopes Market in Global (2022-2032)
  • Table 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
  • Table 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
  • Table 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
  • Table 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
  • Table 7: Sigmoidoscopes Market in North America (2022-2032)
  • Table 8: Sigmoidoscopes Market in the United States (2022-2032)
  • Table 9: Sigmoidoscopes Market in Canada (2022-2032)
  • Table 10: Sigmoidoscopes Market in Mexico (2022-2032)
  • Table 11: Sigmoidoscopes Market in Europe (2022-2032)
  • Table 12: Sigmoidoscopes Market in France (2022-2032)
  • Table 13: Sigmoidoscopes Market in Germany (2022-2032)
  • Table 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
  • Table 15: Sigmoidoscopes Market in Italy (2022-2032)
  • Table 16: Sigmoidoscopes Market in Spain (2022-2032)
  • Table 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
  • Table 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
  • Table 19: Sigmoidoscopes Market in China (2022-2032)
  • Table 20: Sigmoidoscopes Market in Japan (2022-2032)
  • Table 21: Sigmoidoscopes Market in India (2022-2032)
  • Table 22: Sigmoidoscopes Market in Australia (2022-2032)
  • Table 23: Sigmoidoscopes Market in South Korea (2022-2032)
  • Table 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
  • Table 26: Sigmoidoscopes Market in the Middle East (2022-2032)
  • Table 27: Sigmoidoscopes Market in Africa (2022-2032)
  • Table 28: Sigmoidoscopes Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Sigmoidoscopes Market in Global (2022-2032)
  • Figure 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
  • Figure 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
  • Figure 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
  • Figure 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
  • Figure 7: Sigmoidoscopes Market in North America (2022-2032)
  • Figure 8: Sigmoidoscopes Market in the United States (2022-2032)
  • Figure 9: Sigmoidoscopes Market in Canada (2022-2032)
  • Figure 10: Sigmoidoscopes Market in Mexico (2022-2032)
  • Figure 11: Sigmoidoscopes Market in Europe (2022-2032)
  • Figure 12: Sigmoidoscopes Market in France (2022-2032)
  • Figure 13: Sigmoidoscopes Market in Germany (2022-2032)
  • Figure 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
  • Figure 15: Sigmoidoscopes Market in Italy (2022-2032)
  • Figure 16: Sigmoidoscopes Market in Spain (2022-2032)
  • Figure 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
  • Figure 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
  • Figure 19: Sigmoidoscopes Market in China (2022-2032)
  • Figure 20: Sigmoidoscopes Market in Japan (2022-2032)
  • Figure 21: Sigmoidoscopes Market in India (2022-2032)
  • Figure 22: Sigmoidoscopes Market in Australia (2022-2032)
  • Figure 23: Sigmoidoscopes Market in South Korea (2022-2032)
  • Figure 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
  • Figure 26: Sigmoidoscopes Market in the Middle East (2022-2032)
  • Figure 27: Sigmoidoscopes Market in Africa (2022-2032)
  • Figure 28: Sigmoidoscopes Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis